Science Explorer Back to mapMap
Discussion
Topic · Immunology

Atherosclerosis and Cardiovascular Diseases

Atherosclerosis and Cardiovascular Diseases is a research topic within Immunology. Science Explorer counts 29k research works in it since 1950. 10.2% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the immunological mechanisms involved in the development and progression of atherosclerosis. It covers topics such as the role of immune response, inflammation, oxidized LDL, regulatory T cells, cytokines, dendritic cells, adaptive immunity, and the LOX-1 receptor in atherosclerosis. The papers explore how T cell activation and B cell responses contribute to the pathogenesis of atherosclerosis.

  • Atherosclerosis
  • Immune Response
  • Inflammation
  • Oxidized LDL
  • Regulatory T Cells
  • Cytokines
  • Dendritic Cells
  • Adaptive Immunity
  • LOX-1 Receptor
  • T Cell Activation
Research works
29k
fractional, since 1950
In the world top 10%
3k
per year above
Top-10% rate
10.2%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+17%
the tick is no change
Largest producer
China
37% of the 10 largest, 2022-now
Atherosclerosis and Cardiovascular Diseases

Which countries lead Atherosclerosis and Cardiovascular Diseases research?

By volume, China and the United States publish the most (1.5k and 1.2k works in 2022-now).

By volume, 2022-now

  1. 1 China 1.5k works
  2. 2 United States 1.2k works
  3. 3 Germany 220 works
  4. 4 Russia 186 works
  5. 5 India 182 works
  6. 6 Italy 176 works
  7. 7 United Kingdom 174 works
  8. 8 Japan 170 works
  9. 9 Spain 143 works
  10. 10 France 131 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

China: 37.1%United States: 29.4%Germany: 5.3%Russia: 4.5%6 others listed: 23.7%37%largest
China1,528 · 37.1%United States1,209 · 29.4%Germany220 · 5.3%Russia186 · 4.5%6 others listed976 · 23.7%

Shares of the rows listed above, not of the whole node.

Which institutions lead Atherosclerosis and Cardiovascular Diseases research?

By volume in 2022-now, Harvard University publishes the most Atherosclerosis and Cardiovascular Diseases research, followed by Chinese Academy of Medical Sciences & Peking Union Medical College and Capital Medical University.

By volume, 2022-now

  1. 1 Harvard UniversityUnited States 73 works
  2. 2 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 58 works
  3. 3 Capital Medical UniversityChina 48 works
  4. 4 Russian Academy of SciencesRussia 43 works
  5. 5 Shanghai Jiao Tong UniversityChina 34 works
  6. 6 Nanjing Medical UniversityChina 30 works
  7. 7 Central South UniversityChina 30 works
  8. 8 InsermFrance 29 works
  9. 9 Karolinska InstitutetSweden 29 works
  10. 10 Huazhong University of Science and TechnologyChina 29 works

Who are the leading researchers in Atherosclerosis and Cardiovascular Diseases?

The most-cited researchers publishing on Atherosclerosis and Cardiovascular Diseases include George Davey Smith, Walter Churchill Willett and Mark J. Daly.

  1. 1 George Davey Smith United Kingdom 435k citations
  2. 2 Walter Churchill Willett United States 411k citations
  3. 3 Mark J. Daly United States 403k citations
  4. 4 Stacey L. Gabriel United States 402k citations
  5. 5 Robert John Tibshirani United States 396k citations
  6. 6 John J.V. McMurray United Kingdom 349k citations
  7. 7 Hermann Brenner Germany 343k citations
  8. 8 Shizuo Akira Japan 342k citations
  9. 9 Emelia J. Benjamin United States 341k citations
  10. 10 Jun Wang China 340k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Atherosclerosis and Cardiovascular Diseases?

The most cited paper in Atherosclerosis and Cardiovascular Diseases is "Atherosclerosis — An Inflammatory Disease" (Russell Ross, 1999), with 21,815 citations. Next come "The 1982 revised criteria for the classification of systemic lupus erythematosus" (14,664) and "The pathogenesis of atherosclerosis: a perspective for the 1990s" (10,703).

Most cited papers
#PaperReleasedCitations
1 Atherosclerosis — An Inflammatory Disease Russell Ross · New England Journal of Medicine 14 Jan 1999 21,815
2 The 1982 revised criteria for the classification of systemic lupus erythematosus Eng M. Tan, Alan S. Cohen, James F. Fries et al. · Arthritis & Rheumatism Nov 1982 14,664
3 The pathogenesis of atherosclerosis: a perspective for the 1990s Russell Ross · Nature Apr 1993 10,703
4 Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease Paul M. Ridker et al. · New England Journal of Medicine Open access 27 Aug 2017 9,517
5 Inflammation, Atherosclerosis, and Coronary Artery Disease Göran K. Hansson · New England Journal of Medicine 20 Apr 2005 8,822
All 97 most cited papers, with filters and sorting

Where is Atherosclerosis and Cardiovascular Diseases research done?

The largest centres of Atherosclerosis and Cardiovascular Diseases research in 2022-now are Beijing (China), Shanghai (China), Moscow (Russia) and Guangzhou (China). Among places with at least 20 works in it, it is an unusually large share of all research in Charlottesville and Leiden.

Largest cities, 2022-now

  1. 1 BeijingChina 214 works
  2. 2 ShanghaiChina 109 works
  3. 3 MoscowRussia 95 works
  4. 4 GuangzhouChina 88 works
  5. 5 New YorkUnited States 75 works
  6. 6 BostonUnited States 65 works
  7. 7 WuhanChina 61 works
  8. 8 ParisFrance 60 works
  9. 9 NanjingChina 56 works
  10. 10 ChangshaChina 53 works

Where it is the local speciality

  1. CharlottesvilleUS · 21.4 works5.7×
  2. LeidenNL · 20.9 works5.6×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Atherosclerosis and Cardiovascular Diseases than the world average.

See Atherosclerosis and Cardiovascular Diseases on the map

Where is the best place to study Atherosclerosis and Cardiovascular Diseases?

Among universities, judged by research, Harvard University, Chinese Academy of Medical Sciences & Peking Union Medical College and New York University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%10%20%30%mean 17.94%fractional works in this field (log) →share of work in the world top 10% →Harvard UniversityStanford UniversityNew York UniversityChinese Academy of M…
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Harvard UniversityUnited States 84.320.2%4.7×73 +9.4%
2Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 63.714.0%11.2×58 +27.8%
3New York UniversityUnited States 62.918.2%4.2×24 +86.3%
4Stanford UniversityUnited States 62.219.5%2.7×19 +75.9%
5Washington University in St. LouisUnited States 60.827.9%4.4×16 +35.6%
6University of California San DiegoUnited States 60.521.5%2.8×13 +3.1%
7Johns Hopkins UniversityUnited States 59.818.1%3.2×24 +74.3%
8Capital Medical UniversityChina 59.012.2%9.2×48 +29.1%
9Karolinska InstitutetSweden 57.512.1%10.5×29 -22.5%
10Vanderbilt UniversityUnited States 56.515.7%5.8×20 +18.6%

Universities only. The score blends excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Atherosclerosis and Cardiovascular Diseases, country by country

Is Atherosclerosis and Cardiovascular Diseases research growing?

Output in 2022-2025 was 17% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Atherosclerosis and Cardiovascular Diseases.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Atherosclerosis and Cardiovascular Diseases as a percentage of every work published that year, 0.024% in 2024.

still counting0.020%0.040%Atherosclerosis and Cardiovascular Diseases0.023% in 202519801990200020102020

Fractional works of Atherosclerosis and Cardiovascular Diseases over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Atherosclerosis and Cardiovascular Diseases10.1% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Atherosclerosis and Cardiovascular Diseases. Posts are plain text and can be reported.